# US 2026/0153505 A1 · Wearing article provided with test strip for detecting amniotic fluid marker

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2026/0153505 A1
- Document ID: US20260153505A1
- Status: Published application
- Kind: A1
- Application number: 19/121,929
- Filed: 2023-10-19
- Published: 2026-06-04
- Earliest claimed: 2022-10-21
- Assignees: Cranebio Co., Ltd.
- Applicants: Cranebio Co., Ltd.
- Inventors: Keita Saito; Takeru Suzuki; Moto Takeshita; Misato Abe; Iku Sugawara
- Web page: https://patentgrep.com/patent/US20260153505A1

## CPC

- G01N 33/54388: {based on lateral flow}
- A61F 13/84: Accessories, not otherwise provided for, for absorbent pads
- G01N 33/689: {related to pregnancy or the gonads}
- A61F 2013/8488: {including testing apparatus}
- G01N 2333/4745: Insulin-like growth factor binding protein
- G01N 2470/06: Second binding partner specifically binding complex of analyte with first binding partner
- G01N 2800/368: Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- A61F: FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS (dental prosthetics A61C)

## Abstract

Provided is a product that enables easy monitoring of early rupture of membranes and relates to a wearing article provided with a test strip using immunochromatography, wherein the test strip is designed to detect amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion, and wherein, when the test strip detects 0.3-25 mg/L of insulin-like growth factor binding protein 1, the result is considered positive.

## Claims

### Claim 1

A wearable article, comprising a test strip using immunochromatography, wherein
the test strip is for detecting amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion, and
the test strip detects 0.3 μg/L to 25 μg/L of insulin-like growth factor binding protein 1 as positive.

### Claim 2 (depends on 1)

The wearable article according to claim 1, which is an undergarment or absorbent article.

### Claim 3 (depends on 1)

The wearable article according to claim 1, wherein the test strip has a width of 3 mm or less.

### Claim 4 (depends on 1)

The wearable article according to claim 1, wherein the test strip comprises:
a first member which contacts vaginal secretion,
a second member which contains a labeled antibody that recognizes amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion, and
a third member which has a display part which contains a capture antibody,
the capture antibody is capable of capturing a complex formed by binding of the labeled antibody and insulin-like growth factor binding protein 1, and
the test strip is configured such that the amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion moves from the first member, through the second member, to the display part of the third member, and that
the display part of the third member changes color when the capture antibody captures the complex.

### Claim 5 (depends on 4)

The wearable article according to claim 4, wherein the first member, the second member, and the third member are stacked in this order at least partially overlapping each other, and
a sum of thicknesses of the first member, the second member, and the third member in the stacking direction is 1.5 mm or less.

### Claim 6 (depends on 4)

The wearable article according to claim 4, wherein the labeled antibody comprises a colorant having a particle diameter of 250 nm to 500 nm.

### Claim 7

A test strip using immunochromatography for use in a wearable article, wherein
the test strip is for detecting amniotic fluid-derived insulin-like growth factor binding protein 1 in vaginal secretion, and
the test strip detects 0.3 μg/L to 25 μg/L of insulin-like growth factor binding protein 1 as positive.
